Custom Antibody Production Service
End-to-End Antibody Development Services for Research, Diagnostic, and Therapeutic Applications
BioCrest Sci provides custom antibody production services for academic laboratories, biotechnology companies, diagnostic developers, and pharmaceutical research teams. We support multiple antibody generation platforms to help researchers obtain antibodies optimized for specific experimental goals, assay formats, and downstream development requirements.
Our antibody customization services are built on 18 years of protein and antibody expertise, with a focus on transparency, reproducibility, and scientific rigor – not overpromised success rates.
Our Antibody Customization Services
Select the service that matches your project needs. Each option leads to a dedicated service page with detailed workflows, timelines, and technical specifications.
Custom Monoclonal Antibody
High-specificity antibodies from a single clone. Ideal for diagnostic development, flow cytometry, IHC, and long-term reproducibility.
Custom Polyclonal Antibody
Rapid generation of antibody populations recognizing multiple epitopes. Well-suited for WB, ELISA, protein tracking, and exploratory studies.
Custom Recombinant Antibody
Sequence-defined, renewable antibodies with batch-to-batch consistency. Supports engineering, humanization, affinity maturation & scalable manufacturing.
Custom Nanobody (VHH)
Single-domain antibody fragments with small size and high stability. Perfect for intracellular targeting, structural biology, CAR-T, and biosensors.
Neutralizing Antibody
Functionally validated antibodies that block biological activity — viral entry, receptor-ligand interaction, cytokine signaling, or enzymatic inhibition.
Comparison of Antibody Production Platforms
Select the right platform based on your research needs.
| Service Type | Main Advantages | Typical Timeline | Best-Fit Applications |
|---|---|---|---|
| Polyclonal Antibody | Fast and broad epitope recognition | ~2–4 months | WB, ELISA, exploratory studies |
| Monoclonal Antibody | Specificity and reproducibility | ~3–6 months | Diagnostics, flow cytometry, IHC |
| Recombinant Antibody | Sequence-defined renewable reagent | ~1–3 months after sequence | Therapeutic and engineered antibody research |
| Nanobody (VHH) | Small size and high stability | ~3–5 months | Imaging, intracellular targeting, CAR research |
| Neutralizing Antibody | Functional biological inhibition | Variable | Antiviral and blocking studies |
🧬 Antigen Types Supported
Recombinant proteins, peptides (including phosphorylated), membrane proteins, GPCRs, ion channels, viral/bacterial antigens, toxins, haptens, and more.
Our scientists assist with epitope selection, antigen design, and immunization optimization.
🔬 Screening & Validation Options
Customizable screening aligned with your intended application:
- ELISA / MSD binding
- Western blot
- Flow cytometry
- Immunofluorescence (IF/ICC)
- Immunohistochemistry (IHC)
- Neutralization assays
- SPR / BLI affinity
- Cell-based functional assays
- Pair screening for sandwich ELISA
Quality Control & Scientific Transparency
We don't claim 100% success. Instead, we provide honest feasibility assessments and traceable data.
📊 Antigen Integrity
Pre-immunization QC & serum titer monitoring
🧪 Clone Stability
Monoclonal screening & contamination testing
📝 Sequence Verification
For recombinant antibodies + SDS-PAGE, endotoxin, concentration QC
🎯 Application-Specific Validation
Tailored to your downstream assay, not generic testing
💡 If a strategy is unlikely to succeed, we will tell you upfront and recommend an alternative approach.
✅ Why Researchers Choose BioCrest
- Multiple platforms — monoclonal, polyclonal, recombinant, nanobody, neutralizing all in one place
- Difficult target expertise — membrane proteins, conformational epitopes, low-immunogenicity antigens
- Transparent communication — weekly updates, raw data access, honest feasibility assessment
- Flexible project scope — from exploratory generation to engineered functional antibodies
📌 Frequently Asked Questions
Depends on your antigen, timeline, downstream application, and whether you need recombinant or functional antibodies. Our scientists offer free strategy consultation.
Yes. Peptide immunization, recombinant extracellular domains, cell-based immunization, and recombinant screening workflows are available.
Yes. Integrated into monoclonal, nanobody, and recombinant antibody workflows.
Start Your Custom Antibody Project
Discuss your antibody discovery program with our scientific team — antigen strategy, platform selection, screening design, and downstream requirements.
Contact Our Scientists →No obligation · Scientist-to-scientist conversation